 | AA PannettNuffield Department of Clinical Medicine, Molecular Endocrinology Group, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
AA Pannett:Expert Impact
Concepts for whichAA Pannetthas direct influence:Jaw tumor,Hrpt2 parafibromin,Hyperparathyroidism jaw tumor,Encoding parafibromin,Jaw tumor syndrome,Sporadic parathyroid tumors,Cystic features,Parafibromin hyperparathyroidism.
AA Pannett:KOL impact
Concepts related to the work of other authors for whichfor which AA Pannett has influence:Parathyroid carcinoma,Parafibromin expression,Hrpt2 gene,Tumor suppressor,Paf1 complex,Multiple endocrine,Ossifying fibroma.
KOL Resume for AA Pannett
| Year | |
|---|---|
| 2002 | Nuffield Department of Clinical Medicine, Molecular Endocrinology Group, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK |
| Concept | World rank |
|---|---|
| parafibromin hyperparathyroidism | #56 |
| encoding parafibromin | #59 |
| hyperparathyroidism jaw tumor | #60 |
| hpt–jt | #61 |
| –jt | #66 |
| hrpt2 parafibromin | #74 |
| hrpt2 tumor | #88 |
| hyperparathyroidism – | #91 |
| – jaw | #97 |
| gene hyperparathyroidism | #99 |
| Sign-in to see all concepts, it's free! | |
Prominent publications by AA Pannett
We report here the identification of a gene associated with the hyperparathyroidism–jaw tumor (HPT–JT) syndrome. A single locus associated with HPT–JT (HRPT2) was previously mapped to chromosomal region 1q25–q32. We refined this region to a critical interval of 12 cM by genotyping in 26 affected kindreds. Using a positional candidate approach, we identified thirteen different heterozygous, germline, inactivating mutations in a single gene in fourteen families with HPT–JT. The proposed ...
| Known for Jaw Tumor | Encoding Parafibromin | Suppressor Proteins | Gene Hyperparathyroidism | Mutation Screening |
